| 4 min read
A massive cancer drug deal, a new license for gut-targeted drugs, and both regulatory and company-led halts on clinical trials led the news this week.
| 4 min read
Often associated with neurodegenerative disease, amyloid fibrils may also help transport genetic material during fertilization.
| 3 min read
Developed by Inovio Pharmaceuticals, the medicine treats a rare condition caused by HPV. The approval paves the way for an era of novel DNA-based medicines.
| 4 min read
Reversing age-related changes in liver cells reduced circulating amyloid beta and cholesterol in rats, revealing a potential new approach to tackling age-related disease.
| 5 min read
Biomarkers could help researchers identify patients most likely to respond to psychiatric drugs, but translating early promise into clinical success remains a challenge.News
| 4 min read
From interpreting conflicting laboratory results to modelling underrepresented populations, virtual hearts could help researchers assess cardiac safety earlier in drug development.
| 4 min read
FDA guidance, trial results, glioblastoma studies, and more led the news this week.
| 3 min read
A new approach to protein degradation improved mitochondrial function and neuronal survival in cell models of several mitochondrial disorders.
| 2 min read
Researchers tested a new antisense oligonucleotide therapy that turns the maternal healthy genes back on to target the underlying cause of disease.
| 4 min read
Researchers are beginning to uncover differences in brain metabolism and cognitive performance among people with PMOS, but it’s still unknown what drives these changes and whether they have long-term consequences.
| 2 min read
The multi-omics data on nearly half a million tumor cells showed that even cells with almost identical genetic makeup can show radically different behavior.
Cancer Research News
IVDR-certified CytoCell probes for IGH and ATM extend FISH in CLL and myeloma, filling gaps where sequencing turnaround and structural detection fall short
OGT's first dedicated fusion MRD NGS panel targets the roughly one-quarter of AML cases where RNA fusion transcripts, not DNA mutations, define residual disease
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore how surface plasmon resonance can reveal binding kinetics, epitope relationships, and receptor interactions to guide antibody lead optimization.
Explore how enzymatic DNA synthesis can support longer, more complex constructs for genome editing, mRNA, and synthetic biology workflows.
